Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer

Clinical trial NCT00436215 · COMPLETED

Trial details

NCT number: NCT00436215
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasm Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2006-12-12
Primary completion: 2014-06-26
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.